Save your place

Sign in to WhoBought

Please try again later.

Bicara Therapeutics Inc. Common Stock (BCAX) institutional ownership

Latest close $26.27 Jul 30, 2026
Market cap$574M 52-week range SectorHealthcare
Funds holding · Q1 2026
142
reported BCAX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
81 buyers · 61 sellers

Bicara Therapeutics Inc. Common Stock (BCAX) price and institutional activity

Dates

Q1 2026

$0 bought by 81 investors
T. Rowe Price Investment Management, Inc.Vestal Point Capital, LP +79 more
$0 sold by 61 investors
FMR LLCMillennium Management LLC +59 more
Bought Sold Totals per quarter; hover a bar for the names.

Bicara Therapeutics Inc. Common Stock (BCAX) institutional activity · 61

Investor Type Est. change Change Δ Own Date
FMR LLC · Reduced
Change −1.2M Δ Own −37.2% Date Q1 2026
FMR LLC Reduced· Q1 2026 −1.2M −37.2% Q1 2026
Millennium Management LLC · Reduced
Change −278K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −278K Q1 2026
State Street · Reduced
Change −230K Date Q1 2026
State Street Reduced· Q1 2026 −230K Q1 2026
T. Rowe Price Associates · Reduced
Change −183K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −183K Q1 2026
Soleus Capital Management, L.P. · Exited
Change −100K Δ Own −100.0% Date Q1 2026
Soleus Capital Management, L.P. Exited· Q1 2026 −100K −100.0% Q1 2026
Jane Street Group, LLC · Exited
Change −86K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −86K −100.0% Q1 2026
Fil Ltd · Reduced
Change −79K Date Q1 2026
Fil Ltd Reduced· Q1 2026 −79K Q1 2026
Barclays PLC · Reduced
Change −74K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −74K Q1 2026
Y-Intercept (hong Kong) Ltd · Exited
Change −60K Δ Own −100.0% Date Q1 2026
Y-Intercept (hong Kong) Ltd Exited· Q1 2026 −60K −100.0% Q1 2026
Citigroup Inc · Reduced
Change −57K Date Q1 2026
Citigroup Inc Reduced· Q1 2026 −57K Q1 2026
BNP Paribas Financial Markets · Reduced
Change −56K Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −56K Q1 2026
Norges · Exited
Change −43K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −43K −100.0% Q1 2026
Dark Forest Capital Management LP · Exited
Change −38K Δ Own −100.0% Date Q1 2026
Dark Forest Capital Management LP Exited· Q1 2026 −38K −100.0% Q1 2026
Trexquant Investment LP · Exited
Change −37K Δ Own −100.0% Date Q1 2026
Trexquant Investment LP Exited· Q1 2026 −37K −100.0% Q1 2026
Russell Investments Group, Ltd. · Reduced
Change −37K Date Q1 2026
Russell Investments Group, Ltd. Reduced· Q1 2026 −37K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 61

Famous investor activity in Bicara Therapeutics Inc. Common Stock (BCAX)

Bicara Therapeutics Inc. Common Stock (BCAX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Bender Jeremy · Director Grant (A) 39K
Owned 39K Trade date Jul 28, 2026 Filed date Jul 29, 2026
Bender Jeremy Director Grant (A) 39K 39K Jul 28, 2026 Jul 29, 2026
Oliger Christy J. · Director Grant (A) 39K
Owned 39K Trade date Jul 28, 2026 Filed date Jul 29, 2026
Oliger Christy J. Director Grant (A) 39K 39K Jul 28, 2026 Jul 29, 2026
Mazumdar Claire · Director 2 operations −$284K
Price $28.42–$29.68 Qty −10K Owned 362K ΔOwn −2.7% Trade date Jul 10, 2026 Filed date Jul 14, 2026
Mazumdar Claire Director 2 operations $28.42–$29.68 −10K −$284K 362K −2.7% Jul 10, 2026 Jul 14, 2026
Mazumdar Claire · Director 2 operations 0
Price $3.79 Owned 121K Trade date Jul 10, 2026 Filed date Jul 14, 2026
Mazumdar Claire Director 2 operations $3.79 0 121K Jul 10, 2026 Jul 14, 2026
Cohlhepp Ryan · Director Sell −$16K
Price $29.00 Qty −536 Owned 182K ΔOwn −0.3% Trade date Jul 9, 2026 Filed date Jul 10, 2026
Cohlhepp Ryan Director Sell $29.00 −536 −$16K 182K −0.3% Jul 9, 2026 Jul 10, 2026
Cohlhepp Ryan · Director 3 operations −$818K
Price $28.76–$30.35 Qty −28K Owned 182K ΔOwn −13.4% Trade date Jul 8, 2026 Filed date Jul 10, 2026
Cohlhepp Ryan Director 3 operations $28.76–$30.35 −28K −$818K 182K −13.4% Jul 8, 2026 Jul 10, 2026
Cohlhepp Ryan · Director 2 operations 0
Price $3.79 Owned 71K Trade date Jul 8, 2026 Filed date Jul 10, 2026
Cohlhepp Ryan Director 2 operations $3.79 0 71K Jul 8, 2026 Jul 10, 2026
Hyep Ivan · Officer 3 operations −$808K
Price $28.60–$30.31 Qty −28K Owned 130K ΔOwn −17.7% Trade date Jul 8, 2026 Filed date Jul 10, 2026
Hyep Ivan Officer 3 operations $28.60–$30.31 −28K −$808K 130K −17.7% Jul 8, 2026 Jul 10, 2026
Hyep Ivan · Officer 3 operations 0
Price $3.79 Owned 39K Trade date Jul 8, 2026 Filed date Jul 10, 2026
Hyep Ivan Officer 3 operations $3.79 0 39K Jul 8, 2026 Jul 10, 2026
Ra Capital Management, L.P. · Director Grant (A) 19K
Owned 19K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Ra Capital Management, L.P. Director Grant (A) 19K 19K Jun 9, 2026 Jun 10, 2026
Bowden Christopher · Director Grant (A) 19K
Owned 19K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Bowden Christopher Director Grant (A) 19K 19K Jun 9, 2026 Jun 10, 2026
Haviland Kate · Director Grant (A) 19K
Owned 19K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Haviland Kate Director Grant (A) 19K 19K Jun 9, 2026 Jun 10, 2026
Mazumdar-Shaw Kiran · Director Grant (A) 19K
Owned 19K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Mazumdar-Shaw Kiran Director Grant (A) 19K 19K Jun 9, 2026 Jun 10, 2026
Robertson Scott M. · Director Grant (A) 19K
Owned 19K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Robertson Scott M. Director Grant (A) 19K 19K Jun 9, 2026 Jun 10, 2026
Powell Michael · Director Grant (A) 19K
Owned 19K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Powell Michael Director Grant (A) 19K 19K Jun 9, 2026 Jun 10, 2026
15 of 120
15 of 120 Sign in to continue to older insider transactions.

Bicara Therapeutics Inc. Common Stock (BCAX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ra Capital Management, L.P. 7.0M
% of shares outstanding 12.8% Filing date Sep 23, 2024
Ra Capital Management, L.P. 7.0M 12.8% Sep 23, 2024
Vestal Point Capital, LP 5.4M
% of shares outstanding 8.3% Filing date May 15, 2026
Vestal Point Capital, LP 5.4M 8.3% May 15, 2026
Deep Track Capital, LP 4.1M
% of shares outstanding 6.2% Filing date May 15, 2026
Deep Track Capital, LP 4.1M 6.2% May 15, 2026
Invus Global Management, LLC 3.0M
% of shares outstanding 5.6% Filing date Sep 26, 2024
Invus Global Management, LLC 3.0M 5.6% Sep 26, 2024
Tpg Gp A, LLC 3.0M
% of shares outstanding 5.5% Filing date Sep 18, 2024
Tpg Gp A, LLC 3.0M 5.5% Sep 18, 2024
Blackrock, Inc. 3.5M
% of shares outstanding 5.4% Filing date Jul 27, 2026
Blackrock, Inc. 3.5M 5.4% Jul 27, 2026
Janus Henderson Group PLC 3.3M
% of shares outstanding 5.1% Filing date May 15, 2026
Janus Henderson Group PLC 3.3M 5.1% May 15, 2026
Red Tree Gp, LLC 3.2M
% of shares outstanding 4.8% Filing date May 8, 2026
Red Tree Gp, LLC 3.2M 4.8% May 8, 2026
8 of 9

Bicara Therapeutics Inc. Common Stock (BCAX) ownership FAQ

Who owns BCAX?

142 reporting institutions disclosed BCAX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.